The Global Virtual Clinical Trials Market is valued at USD 8.46 billion in 2024 and is projected to reach a market size of USD 12.47 billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 5.7%.
Industry Overview
Virtual trials employ dedicated apps for patient involvement and tracking and are based on telemedicine. They significantly lessen the financial and time commitments. Furthermore, AI technology can assist in the synthesizing and analysis of ever-increasing data while also speeding up the process. Because of these advantages, life science businesses and clinical trial sponsors are increasingly interested in Virtual Clinical Trialss.
"Artificial intelligence is likely to play a significant role in Virtual Clinical Trialss." Virtual trials will increasingly include conversational AI for natural language processing (NLP) and image-based AI. "Conversational AI helps maintain patient-clinician interaction, while imaging AI plays a critical role in studies requiring radiology," says the CTO of Leading Clinical Trial Solutions. The volume and complexity of clinical trials have increased due to an increase in the R&D of novel medications and vaccines. Virtual Clinical Trialss alleviate the problems that traditional clinical studies problems, such as patient recruitment delays and lengthy processes. Furthermore, studies show that 75.0 percent of people prefer mobile trials to traditional trials and that 80.0 percent of patients are more inclined to engage in a clinical trial that incorporates mobile technology.
Impact of Covid-19 on the Industry
The pandemic of COVID-19 has had a huge influence on the market. The market is primarily driven by an increase in R&D efforts, increased healthcare digitization, and telehealth use. Furthermore, the market is expected to be driven by technical developments, alliances between clinical research institutions, pharmaceutical, and biotechnology businesses, as well as supportive government efforts. The COVID-19 epidemic is forcing the clinical trial industry to rethink how it conducts current and future trials. After the epidemic, the market is rapidly recovering since it provides numerous benefits to both patients and sponsors. Traveling was possibly harmful during the pandemic. It can be costly, resulting in lost pay or the need to employ childcare or eldercare. These disadvantages serve as a deterrent to initial interest while also providing a straightforward solution for Virtual Clinical Trialss. Virtual Clinical Trialss have several advantages, including efficient data collecting, processing, and real-time monitoring of massive amounts of data.
Following Covid, the number of venture capital funding agreements has surged. In 2018, there were six deals, which will expand to 18 by 2020. The majority of VC funding occurred in the third quarter of 2020. (10 deals). Medable, for example, has raised $524 million in several rounds since 2020, making it one of the fastest-growing decentralized trials platform providers. The company obtained a significant $304 million Series D fundraising round in October 2021, which was one of the biggest rounds. Companies will be able to make technology breakthroughs and expand their client and geographic reach as VC funding increases.
Market Drivers
Nation-wide lockdowns all over the globe pushed the market growth
The global market has recently seen a significant increase due to the Covid-19 outbreak around the world. Digital technologies, virtual trials, and telemedicine are being developed by biopharma businesses and regulatory bodies as viable options for limiting trial interruptions. Virtual visits and remote monitoring via telemedicine have been advised by the Food and Drug Administration as an alternative to in-person visits. Companies, on the other hand, have attempted to bring about a shift through technology development to meet the fast-increasing digitization of healthcare.
Technological advancement in the pharmaceutical and healthcare sector
Furthermore, advancements in technology in the healthcare business are expected to contribute to the market's overall growth. Direct shipment of IMPs (investigative medicinal products) to patients is one feature of the decentralized (virtual) trials that has gained pace in recent years and is predicted to boost the global market growth. Companies and research centers are adopting new technologies which help patients to diagnose their disease from home using their mobile phones or small devices.
Increase in the number of chronic disease patients
An increase in the number of people suffering from chronic diseases, infectious diseases, and neurological diseases, as well as an increase in the worldwide geriatric population, are some of the reasons driving the global market's expansion. According to the Centers for Conditions Control and Prevention, in the United States, 6 out of 10 people have a chronic disease, and 4 out of 10 people have two or more, making the chronic disease the largest cause of mortality in the country. This is also expected to encourage technological advancements in the healthcare business, consequently boosting market growth.
Rising demand for the Oncology sector
In 2021, the oncology category dominated the market for Virtual/Decentralized Clinical Trials, accounting for 25.2 percent of total revenue. During the projected period, the segment is also expected to contribute the most share of the market. This is due to an increase in the number of oncology clinical trials and an increase in the number of cancer patients worldwide. During the COVID-19 pandemic, cancer patients are the most vulnerable. Oncology clinical trial investigators and sponsors have swiftly adopted virtual and remote trials to keep patients safe and studies going ahead.
Market Restraints
A greater amount of Data Collection is needed for this diagnosis
Diagnosing various diseases through mobile devices with a high level of accuracy needs a large amount of data analysis. Collecting such data is costly. For the data of such an amount to be available for the mobile diagnosis will take some time.
This research report on the global Virtual Clinical Trials market has been segmented and sub-segmented based on Product type, application, end-user, and region.
In 2021, the interventional design sector dominated the Virtual/Decentralized Clinical Trials (DCTs) market, accounting for 45% of total revenue. The industry is being driven by the rapid expansion in the number of experiments being conducted to produce novel drugs for various diseases, as well as the digitalization of laboratories. The global coronavirus outbreak has increased the need for testing and trials of novel medications and vaccines to tackle the problem, as the usual approach of clinical trials carries a significant risk of infection in individuals. As a result, the demand for interventional study designs is increasing.
Cardiovascular disorders, immunology, gastrointestinal, dermatological, respiratory, and endocrinology, as well as less interventional observational research, are more suitable for virtual trials. The company that pioneered this concept used its mobile telemedicine-based platform, "NORA," to conduct a complete interventional Phase 2b "site-less" clinical study with 372 patients across ten states. Over the forecast period, the expanded access segment is expected to have the greatest CAGR. Extended access is a possible avenue that is appropriate when the potential benefit for the patient outweighs the potential dangers; thus, the constant development of new COVID-19 variations is predicted to fuel demand for expanded access to new medications shortly.
In 2021, the oncology segment dominated the market for Virtual/Decentralized Clinical Trials, accounting for 25% of total revenue. During the projected period, the segment is also expected to contribute the most share of the market. This is due to an increase in the number of oncology clinical trials and an increase in the number of cancer cases worldwide. During the COVID-19 pandemic, cancer patients are the most vulnerable. Oncology clinical trial investigators and sponsors have quickly adopted virtual and remote trials to keep patients safe and trials going forward.
Furthermore, cancer researchers encounter significant difficulties in recruiting patients. Approximately 14, 000 cancer trials were actively recruiting as of June 2019, with a participation rate of 3% to 8% of potential candidates, with substantially less in minority and senior populations. Low enrolment rates jeopardize the effectiveness of specific clinical research, since they may stymie therapy advancements and their associated advantages to outcomes. As a result of the poor recruitment rate and the requirement for a broad population for oncology clinical trials, Virtual Clinical Trialss are expected to grow in popularity.
North America dominated the Virtual Clinical Trialss market in 2021, accounting for 49.2 percent of total revenue. Over the forecast period, the category is expected to maintain its dominance. This is due to increased R&D in the region, as well as increased adoption of new technology in clinical research and government funding. Digital technologies are likewise being used by market participants to suit customer wants. Parexel, for example, conducted over 100 decentralized trials, including hybrid and virtual techniques. Patients can participate in the research at one of Covance's 1,900 LabCorp Patient Service Centers across the United States.
The market for Virtual Clinical Trialss in the Asia Pacific is expected to grow at the fastest CAGR of 6.8% during the forecast period, owing to the increasing availability of a large patient pool that allows for easy recruitment of candidates, as well as the region's increased adoption of digital technologies. Furthermore, the coronavirus outbreak is expected to increase telemedicine use, propelling the market in the region. In 2020, Japan was the largest market in the Asia Pacific, owing to high healthcare and R&D spending, as well as rising demand for Virtual Clinical Trialss.
Global Virtual Clinical Market- By Companies
NOTABLE HAPPENINGS IN THE GLOBAL Virtual Clinical Trials MARKET IN THE RECENT PAST:
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
According to the report published by Virtue Market Research in Global Virtual Clinical Trials Market was valued at USD 8 billion and is projected to reach a market size of USD 12.46 billion by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 5.7%.
Segments covered in the Virtual Clinical Trials Market report are: Study Design, Indication, Geography
Yes, this report covers COVID19 impact analysis.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
